Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Phillips-Medisize A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmarkIFRS Analyst: XBRLDenmarkIFRS

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1.0 Bankruptcy Risk  2016 2016/12 2017 N/A 2018 N/A 2019 N/A 2020 N/A 2021 2021/12 2022e N/A 2023e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   5.2% 0.0% 0.0% 0.0% 0.0% 0.5% 4.9% 4.4%   Credit score (0-100)   45 0 0 0 0 98 44 46   Credit rating   BBB N/A N/A N/A N/A AA BBB BBB   Credit limit (mDKK)   0.0 0.0 9.4 13.0 13.6 19.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1.0 Income statement (mDKK)  2016 2016/12 2017 N/A 2018 N/A 2019 N/A 2020 N/A 2021 2021/12 2022e N/A 2023e N/A Net sales   175 0 210 264 275 361 361 361   Gross profit   175 0.0 210 264 275 80.8 0.0 0.0   EBITDA   165 0.0 20.0 27.0 13.0 50.2 0.0 0.0   EBIT   165 0.0 20.0 27.0 13.0 50.2 0.0 0.0   Pre-tax profit (PTP)   -2.1 0.0 20.0 27.0 12.0 47.4 0.0 0.0   Net earnings   -2.1 0.0 15.0 21.0 10.0 36.9 0.0 0.0   Pre-tax profit without non-rec. items   165 0.0 20.0 27.0 13.0 47.4 0.0 0.0     See the entire income statement 1.0 Balance sheet (mDKK)  2016 2016/12 2017 N/A 2018 N/A 2019 N/A 2020 N/A 2021 2021/12 2022e N/A 2023e N/A Tangible assets total   1.9 0.0 0.0 0.0 0.0 39.0 0.0 0.0   Shareholders equity total   18.9 0.0 41.0 62.0 71.8 109 92.0 92.0   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 47.0 0.0 0.0   Balance sheet total (assets)   70.5 0.0 0.0 0.0 0.0 245 92.0 92.0   Net Debt   -19.0 0.0 0.0 0.0 0.0 -65.7 -89.4 -89.4     See the entire balance sheet 1.0 Volume  2016 2016/12 2017 N/A 2018 N/A 2019 N/A 2020 N/A 2021 2021/12 2022e N/A 2023e N/A Net sales   175 0 210 264 275 361 361 361   Net sales growth   0.0% -100.0% 0.0% 25.7% 4.2% 31.1% 0.0% 0.0%   Gross profit   175 0.0 210 264 275 80.8 0.0 0.0   Gross profit growth   0.0% -100.0% 0.0% 25.7% 4.2% -70.6% -100.0% 0.0%   Employees   0 0 0 0 0 180 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   70 0 0 0 0 245 92 92   Balance sheet change%   0.0% -100.0% 0.0% 0.0% 0.0% 0.0% -62.4% 0.0%   Added value   164.6 0.0 20.0 27.0 13.0 50.2 0.0 0.0   Added value %   94.1% 0.0% 9.5% 10.2% 4.7% 13.9% 0.0% 0.0%   Investments   2 -2 0 0 0 42 -39 0   Net sales trend   0.0 -1.0 0.0 1.0 2.0 3.0 0.0 0.0   EBIT trend   1.0 0.0 1.0 2.0 3.0 4.0 0.0 0.0   1.0 Profitability  2016 2016/12 2017 N/A 2018 N/A 2019 N/A 2020 N/A 2021 2021/12 2022e N/A 2023e N/A EBITDA %   94.1% 0.0% 9.5% 10.2% 4.7% 13.9% 0.0% 0.0%   EBIT %   94.1% 0.0% 9.5% 10.2% 4.7% 13.9% 0.0% 0.0%   EBIT to gross profit (%)   94.1% 0.0% 9.5% 10.2% 4.7% 62.2% 0.0% 0.0%   Net Earnings %   -1.2% 0.0% 7.1% 8.0% 3.6% 10.2% 0.0% 0.0%   Profit before depreciation and extraordinary items %   -1.2% 0.0% 7.1% 8.0% 3.6% 10.2% 0.0% 0.0%   Pre tax profit less extraordinaries %   94.1% 0.0% 9.5% 10.2% 4.7% 13.1% 0.0% 0.0%   ROA %   233.6% 0.0% 0.0% 0.0% 0.0% 21.2% 0.0% 0.0%   ROI %   233.6% 0.0% 0.0% 0.0% 0.0% 32.9% 0.0% 0.0%   ROE %   -10.9% 0.0% 36.6% 20.4% 7.5% 20.5% 0.0% 0.0%   1.0 Solidity  2016 2016/12 2017 N/A 2018 N/A 2019 N/A 2020 N/A 2021 2021/12 2022e N/A 2023e N/A Equity ratio %   100.0% 0.0% 100.0% 100.0% 100.0% 54.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 37.7% 0.0% 0.0%   Relative net indebtedness %   -10.9% 0.0% 0.0% 0.0% 0.0% 6.4% -24.8% -24.8%   Net int. bear. debt to EBITDA, %   -11.5% 0.0% 0.0% 0.0% 0.0% -130.8% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 43.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 19.1% 0.0% 0.0%   1.0 Liquidity  2016 2016/12 2017 N/A 2018 N/A 2019 N/A 2020 N/A 2021 2021/12 2022e N/A 2023e N/A Quick Ratio   0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0   Current Ratio   0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0   Cash and cash equivalent   19.0 0.0 0.0 0.0 0.0 112.8 0.0 0.0   1.0 Capital use efficiency  2016 2016/12 2017 N/A 2018 N/A 2019 N/A 2020 N/A 2021 2021/12 2022e N/A 2023e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   29.8% 0.0% 0.0% 0.0% 0.0% 55.4% 24.8% 24.8%   Net working capital   52.1 0.0 0.0 0.0 0.0 66.6 0.0 0.0   Net working capital %   29.8% 0.0% 0.0% 0.0% 0.0% 18.5% 0.0% 0.0%   1.0 Employee efficiency  2016 2016/12 2017 N/A 2018 N/A 2019 N/A 2020 N/A 2021 2021/12 2022e N/A 2023e N/A Net sales / employee   0 0 0 0 0 2 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0